当前位置: 首页 > 期刊 > 《新医学》 > 20206
编号:13473819
口服细胞穿膜肽Penetratin对小鼠肝脏、肾脏和肠道的急性毒性反应研究(4)
http://www.100md.com 2020年6月1日 《新医学》 20206
     [3] Pescina S, Ostacolo C, Gomez-Monterrey IM, Sala M, Bertamino A, Sonvico F, Padula C, Santi P, Bianchera A, Nicoli S. Cell penetrating peptides in ocular drug delivery: state of the art. J Control Release, 2018, 284:84-102.

    [4] Pooga M, Langel ?. Classes of cell-penetrating peptides. Methods Mol Biol, 2015, 1324:3-28.

    [5] Rádis-Baptista G, Campelo IS, Morlighem JRL, MeloLM, Freitas VJF. Cell-penetrating peptides (CPPs): from delivery of nucleic acids and antigens to transduction of engineered nucleases for application in transgenesis. J Biotechnol, 2017, 252:15-26.

    [6] Kristensen M, Birch D, M?rck Nielsen H. Applications and challenges for use of cell-penetrating peptides as delivery vectors for peptide and protein cargos. Int J Mol Sci, 2016, 17(2).pii: E185.

    [7] 謝洋洋,王邵娟,袁权,夏宁邵. 细胞穿膜肽研究应用的新进展. 生物工程杂志, 2019, 35(7): 1162-1173.

    [8] Tünnemann G, Ter-Avetisyan G, Martin RM, St?ckl M, Herrmann A, Cardoso MC. Live-cell analysis of cell penetration ability and toxicity of oligo-arginines. J Pept Sci, 2008, 14(4): 469-476.

    [9] Nielsen EB, Kamei N, Takeda-Morishita M. Safety of the cell-penetrating peptide penetratin as an oral absorption. Biol Pharm Bul, 2015, 38(1):144-146.

    (收稿日期:2019-12-18)

    (本文编辑:杨江瑜), 百拇医药(魏振宇 李林 尉秀清)
上一页1 2 3 4